Anatomic Pathology Market to exceed US$ 53.27 Billion by 2031

    Published on 28-Aug-2024
         Request For Sample

    Report : Anatomic Pathology Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product and Services [Services (Histopathology and Cytopathology), Instruments (Microtomes and Cryostat, Automatic Stainers, Tissue Processors, and Others), and Consumables], Application (Disease Diagnosis, Drug Discovery and Development, and Others), End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

    Disease Diagnosis Segment, by Application to Account Largest Share in Anatomic Pathology Market during 2023-2031

    According to our new research study on "Anatomic Pathology Market Forecast to 2031 - Global Analysis - by Products and Services, Application, End User, and Geography," the market was valued at US$ 30.22 billion in 2023 and is projected to reach US$ 53.27 billion by 2031; it is expected to register a CAGR of 7.3% during 2023-2031. The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are contributing to the anatomic pathology market growth. However, the shortage of skilled professionals and stringent government regulations hamper the market growth. Further, the integration of artificial intelligence and machine learning is expected to bring new anatomic pathology market trends in the coming years.

    Digital pathology, a growing subfield within anatomical pathology, uses digital technologies to streamline data collection and management. It helps reduce risks to specimen samples and has the potential to accelerate enrolment in clinical trials. Additionally, digital pathology can reduce sample-to-result turnaround time and streamline the central pathology review process, further offering opportunities to increase trial efficiency.

    To introduce upgraded technologies, machine learning (ML) and artificial intelligence (AI) are integrated with digital pathology for proper analysis and management of data. Several anatomic pathology laboratories are becoming increasingly aware of the benefits of digitization and AI in practice. Moreover, recent technological advancements and regulatory approvals are encouraging the digitalization of laboratory operations to improve the speed and accuracy of processes. With AI and ML, pathologists will have an augmented ability to improve diagnostic accuracy, efficiency, and consistency.

    In November 2023, Dedalus Group and Ibex Medical Analytics launched a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnostics. It enables complete digitization of anatomic pathology labs with a next-generation Anatomic Pathology Information System (AIS) and DP solution, harnessing the power of data and AI for assisted case prioritization, advanced image analysis, and reproducible diagnoses. The rising focus on integrating AI technology for anatomical pathology processes due to its benefits is expected to act as a trend and is expected to fuel the growth of the market in the forecast period.

    Based on products and services, the anatomic pathology market is segmented into instruments, consumables, and services. The services segment is further bifurcated into histopathology and cytopathology. The instruments segment is further divided into microtomes and cryostat, automatic stainers, tissue processors, and others. The instruments segment held the largest market share in 2023. The instruments that are used in anatomic pathology practices include basic pathology equipment such as microtome, a tool to cut extremely thin sections for materials such as bones, minerals, and teeth; an automatic slide stainer that highlights the structures in biological tissues and provides a more detailed look at the sample; biomedical specimen cabinets that are used as storage systems to organize the supply of laboratories; cooling plate; paraffin trimmer/dispenser; and slide dryer. Microtome is used as an alternative to electropolishing and ion milling. Tissue processing systems that are used in anatomic pathology include tissue embedding systems, tissue floating systems, tissue processors, and tissue water bath instruments. Apart from these, many more advanced and automated devices are used in anatomic pathology, which vary from process to process, depending upon the test to be performed for diagnosis. These machines are complex to handle, and thus, proper training is required to perform tasks as per the requirements of the planned experiments. The growing adoption of automation is expected to boost the market for anatomic pathology instruments during the forecast period.

    By application, the market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest market share in 2023.

    Based on end user, the anatomic pathology market is divided into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest market share in 2023. Hospitals account for the largest share of the anatomic pathology market due to the increasing prevalence of chronic illnesses, which require advanced diagnostic tests and tools, long-term care, and regular monitoring. Anatomic pathology majorly involves necropsy, cytopathology, histopathology, immunopathology, and cytopathology techniques. All these fields are related to the diagnosis and treatment of severe chronic diseases such as heart disease, cancer, and tumors. Anatomic pathology is also used in the study of kidney and liver diseases, autoimmune disorders, and infections. An increase in the number of hospitals and critical care centers, along with a rise in government initiatives for improving healthcare services, is projected to fuel the use of anatomical pathology equipment and services in hospitals.

    F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the leading companies operating in the global anatomic pathology market.

    Companies operating in the anatomic pathology market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the anatomic pathology market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall anatomic pathology market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

    Contact Us
    Contact Person: Sameer Joshi
    Phone: +1-646-491-9876
    Email Id: sales@premiummarketinsights.com

    Get Free Sample PDF

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Have a Question?


    Recent Posts